Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Opinion
January 25, 2019 12:00 AM

Editorial: Left to their own devices

Merrill Goozner
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Merrill Goozner

    Guess which segment of the healthcare industry gets what it wants on every issue it puts before Congress or the agency in charge of its regulation. Hint: It's not the drug industry.

    While every sector involved in delivering or insuring healthcare gets taxed to help pay for the insurance expansion under the Affordable Care Act, this subsector managed to wiggle out of its obligations.

    In 2007, Congress asked this industry to label each of its products with a machine-readable identifier to promote safety, manage recalls and increase supply chain efficiency. More than a decade later, implementation still isn't finished.

    This industry's failures can be life-threatening. Yet despite repeated outcries from physicians and patient advocates, it retains an approval process that absolves many of its most critical and expensive products from comprehensive clinical trial testing for safety and efficacy.

    By now you recognize I'm talking about the medical-device industry. Led by a few Fortune 500 companies making implantable cardiovascular and orthopedic devices and expensive imaging equipment, it includes hundreds of small and midsize firms making everything from bedpans to surgical instruments.

    Their geographic diffusion is often cited as the root of its power. Local representatives from both parties are susceptible to the industry's grass-roots lobbying.

    As a result, ideology plays almost no role in policymaking. When it comes to the device industry, the mantra “jobs, jobs, jobs” trumps safety and science. The Democratic senators from two of the more liberal states in the nation—Minnesota and Massachusetts—have consistently sided with two of the industry's biggest devicemakers: Boston Scientific and Minneapolis-based Medtronic.

    This month brought another awe-inspiring exercise of the industry's enormous influence. Amid a government shutdown that has idled nearly a million Americans, including non-essential personnel at the Food and Drug Administration, that agency managed to put out regulatory guidance that will give devicemakers another pathway for skipping out on clinical trials on devices inserted into American patients.

    It involves the 510(k) process, which grants easier FDA approvals for new devices that are deemed “substantially equivalent” to a device already FDA-approved. All you have to do is demonstrate through bench testing that it's engineered in a similar fashion. No clinical trials required.

    Examples of the disastrous medical consequences of this loophole include defibrillators with poorly designed electrical leads and unsafe surgical meshes. Johnson & Johnson has set aside $2.5 billion for patient lawsuits involving faulty hip implants approved through the 510(k) process, and, one day before the FDA announced its new guidance, agreed to pay $120 million to state attorneys general for making false claims about the devices' safety.

    Despite these notable failures, the FDA's latest plan will allow manufacturers to skip already paltry bench tests in favor of an “appropriate performance criteria standard” that is “less burdensome” than the previous standard. It will be left up to FDA inspectors to develop performance criteria that are “at least as robust.”

    In other words, not only will no clinical trials be required of these new follow-on devices, the company will be able to submit data showing its new device meets criteria that were created by FDA inspectors and company officials sitting in a room mulling over the possibilities.

    Compare that to the hurdles put in the way of biosimilar manufacturer applications. Nearly every approval required safety and efficacy testing in more patients than had been tested in the trials leading to the approval of the innovator company's original drug. Most included head-to-head comparison trials.

    Bills aimed at curbing the drug industry's pricing power are lining up for committee hearings like planes landing in Chicago after a snowstorm. It's time for the relevant committees to tackle the regulation and prices of expensive and potentially dangerous devices, which are being inserted every day in thousands of patients in America's hospitals.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    legal-drugs1 (1).png
    Merck sues federal government, accuses Medicare drug price negotiation plan of 'extortion'
    Shannon Striebich-01_i.jpg
    Trinity Health president speaks on financial problems with new operational solutions
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing